FDA Expands Arctic Front Family of Cryoablation Catheters for Initial Use in Recurrent Symptomatic Paroxysmal AF
June 23, 2021 — The U.S. Food and Drug Administration (FDA) expanded approval for Medtronic’s Arctic Front Family of cardiac cryoablation catheters for the treatment of recurrent symptomatic paroxysmal atrial fibrillation (AFib). The indication is for episodes that last less than seven continuous days and the therapy can be used as an alternative to antiarrhythmic drug (AAD) therapy as an initial…
